Corteva, Inc. $CTVA Shares Acquired by Nomura Asset Management Co. Ltd.

Nomura Asset Management Co. Ltd. raised its stake in shares of Corteva, Inc. (NYSE:CTVA) by 16.2% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 405,316 shares of the company’s stock after acquiring an additional 56,438 shares during the period. Nomura Asset Management Co. Ltd. owned approximately 0.06% of Corteva worth $27,168,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Annis Gardner Whiting Capital Advisors LLC boosted its holdings in shares of Corteva by 9.1% in the fourth quarter. Annis Gardner Whiting Capital Advisors LLC now owns 1,674 shares of the company’s stock valued at $112,000 after acquiring an additional 140 shares in the last quarter. Drive Wealth Management LLC increased its stake in shares of Corteva by 3.8% during the fourth quarter. Drive Wealth Management LLC now owns 4,259 shares of the company’s stock worth $285,000 after acquiring an additional 156 shares during the period. Reynders McVeigh Capital Management LLC increased its stake in shares of Corteva by 2.9% during the fourth quarter. Reynders McVeigh Capital Management LLC now owns 5,686 shares of the company’s stock worth $381,000 after acquiring an additional 160 shares during the period. Chesapeake Capital Corp IL increased its stake in shares of Corteva by 0.9% during the fourth quarter. Chesapeake Capital Corp IL now owns 18,035 shares of the company’s stock worth $1,209,000 after acquiring an additional 161 shares during the period. Finally, Fox Run Management L.L.C. increased its stake in shares of Corteva by 5.1% during the third quarter. Fox Run Management L.L.C. now owns 3,361 shares of the company’s stock worth $227,000 after acquiring an additional 164 shares during the period. 81.54% of the stock is currently owned by hedge funds and other institutional investors.

Corteva Stock Performance

NYSE:CTVA opened at $77.71 on Tuesday. The firm’s fifty day simple moving average is $81.32 and its 200 day simple moving average is $74.68. The company has a current ratio of 1.47, a quick ratio of 1.03 and a debt-to-equity ratio of 0.07. Corteva, Inc. has a twelve month low of $60.53 and a twelve month high of $85.63. The firm has a market capitalization of $51.98 billion, a price-to-earnings ratio of 45.71, a PEG ratio of 2.39 and a beta of 0.59.

Corteva (NYSE:CTVA) last issued its quarterly earnings data on Tuesday, May 5th. The company reported $1.50 earnings per share for the quarter, beating analysts’ consensus estimates of $1.18 by $0.32. Corteva had a return on equity of 9.95% and a net margin of 6.50%.The firm had revenue of $4.91 billion during the quarter, compared to analyst estimates of $4.64 billion. During the same quarter last year, the firm earned $1.13 EPS. Corteva’s quarterly revenue was up 11.0% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, equities research analysts expect that Corteva, Inc. will post 3.72 earnings per share for the current fiscal year.

Corteva Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, June 15th. Stockholders of record on Monday, June 1st will be given a dividend of $0.18 per share. The ex-dividend date is Monday, June 1st. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. Corteva’s payout ratio is currently 42.35%.

Wall Street Analysts Forecast Growth

Several brokerages have weighed in on CTVA. Deutsche Bank Aktiengesellschaft upped their target price on shares of Corteva from $90.00 to $100.00 in a research report on Monday, May 11th. Zacks Research lowered shares of Corteva from a “strong-buy” rating to a “hold” rating in a research report on Friday, February 20th. Wolfe Research upped their target price on shares of Corteva from $81.00 to $86.00 and gave the stock an “outperform” rating in a research report on Thursday, February 5th. The Goldman Sachs Group upped their target price on shares of Corteva from $88.00 to $96.00 and gave the stock a “buy” rating in a research report on Tuesday, April 14th. Finally, Weiss Ratings upgraded shares of Corteva from a “hold (c)” rating to a “hold (c+)” rating in a research report on Thursday, May 7th. Fourteen investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $88.67.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.